|
TR199901968T2
(xx)
*
|
1996-12-24 |
1999-12-21 |
Biogen, Inc. |
Sabit s�v� interferon form�lleri.
|
|
US20030190307A1
(en)
|
1996-12-24 |
2003-10-09 |
Biogen, Inc. |
Stable liquid interferon formulations
|
|
EP1426058A3
(de)
|
1997-09-23 |
2004-07-28 |
Dr. Rentschler Biotechnologie GmbH |
Flüssige Interferon-Beta Formulierungen
|
|
CN100448482C
(zh)
*
|
1999-05-31 |
2009-01-07 |
三菱化学株式会社 |
Hgf冻干制剂
|
|
US6887462B2
(en)
|
2001-04-09 |
2005-05-03 |
Chiron Corporation |
HSA-free formulations of interferon-beta
|
|
AR034749A1
(es)
*
|
2001-07-09 |
2004-03-17 |
Schering Ag |
Formulaciones de interferon beta humano
|
|
EP1458408B1
(en)
|
2001-12-21 |
2009-04-15 |
Novo Nordisk Health Care AG |
Liquid composition of factor vii polypeptides
|
|
EP1475098B1
(en)
*
|
2002-01-18 |
2015-08-05 |
Asahi Kasei Pharma Corporation |
High-concentration preparation of soluble thrombomodulin
|
|
CN1671410B
(zh)
|
2002-06-21 |
2010-05-12 |
诺和诺德医疗保健公司 |
因子ⅶ多肽的稳定化固体组合物
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
US7897734B2
(en)
|
2003-03-26 |
2011-03-01 |
Novo Nordisk Healthcare Ag |
Method for the production of proteins
|
|
TWI272948B
(en)
|
2003-05-01 |
2007-02-11 |
Ares Trading Sa |
HSA-free stabilized interferon liquid formulations
|
|
AR044302A1
(es)
|
2003-05-13 |
2005-09-07 |
Ares Trading Sa |
Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
|
|
RU2364609C2
(ru)
|
2003-05-23 |
2009-08-20 |
Ново Нордиск Хелт Кэр Аг |
Стабилизация белка в растворе
|
|
CN1318087C
(zh)
*
|
2003-06-06 |
2007-05-30 |
北京三诺佳邑生物技术有限责任公司 |
去白蛋白神经生长因子制剂
|
|
JP5653572B2
(ja)
|
2003-08-14 |
2015-01-14 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
第ｖｉｉ因子ポリペプチドの液状水性医薬組成物
|
|
KR20070010115A
(ko)
*
|
2003-11-13 |
2007-01-22 |
알자 코포레이션 |
경피전달용 조성물 및 장치
|
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
|
CN1917861B
(zh)
|
2003-12-19 |
2012-03-21 |
诺和诺德医疗保健公司 |
因子vii多肽的稳定化固体组合物
|
|
CA2567309A1
(en)
*
|
2004-06-01 |
2005-12-15 |
Ares Trading S.A. |
Method of stabilizing proteins
|
|
KR101149454B1
(ko)
*
|
2004-08-24 |
2012-05-25 |
간가와 겐지 |
생리활성 펩티드의 액상 제제
|
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
|
ES2318575T3
(es)
|
2004-11-10 |
2009-05-01 |
Novartis Vaccines And Diagnostics, Inc. |
Interferon beta desamidado.
|
|
AU2006204937B2
(en)
*
|
2005-01-12 |
2011-02-10 |
Biogen Ma Inc. |
Method for delivering Interferon-beta
|
|
CA2593112A1
(en)
*
|
2005-01-21 |
2006-07-27 |
Alza Corporation |
Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion
|
|
DE602006020568D1
(de)
|
2005-07-02 |
2011-04-21 |
Arecor Ltd |
Stabile wässrige systeme mit proteinen
|
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP2540725A1
(de)
|
2006-05-04 |
2013-01-02 |
Boehringer Ingelheim International GmbH |
Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
|
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
|
ES2638977T3
(es)
*
|
2007-12-04 |
2017-10-24 |
Biogen Chesapeake Llc |
Formulaciones y procedimientos mejorados para liofilización y liofilizados obtenidos por los mismos
|
|
JP5563475B2
(ja)
|
2007-12-20 |
2014-07-30 |
メルク セローノ ソシエテ アノニム |
Ｐｅｇインターフェロン−ベータ製剤
|
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
|
CN102066401A
(zh)
|
2008-05-01 |
2011-05-18 |
艾瑞克有限公司 |
蛋白质制品
|
|
EP2328607A1
(en)
|
2008-07-16 |
2011-06-08 |
Arecor Limited |
Stable formulation of a therapeutic protein
|
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
|
CN102149407A
(zh)
|
2008-09-10 |
2011-08-10 |
贝林格尔.英格海姆国际有限公司 |
治疗糖尿病和相关病症的组合疗法
|
|
DE102008051574A1
(de)
|
2008-10-14 |
2010-04-15 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verfahren zur Herstellung von Interferon-beta und deren Varianten
|
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
|
CN102256976A
(zh)
|
2008-12-23 |
2011-11-23 |
贝林格尔.英格海姆国际有限公司 |
有机化合物的盐形式
|
|
AR074990A1
(es)
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
|
DE102009032179A1
(de)
|
2009-07-07 |
2011-01-13 |
Biogenerix Ag |
Verfahren zur Reinigung von Interferon beta
|
|
KR20240090632A
(ko)
|
2009-11-27 |
2024-06-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
|
|
WO2011095543A1
(en)
|
2010-02-04 |
2011-08-11 |
Csl Behring Ag |
Immunoglobulin preparation
|
|
EP2361636A1
(en)
|
2010-02-26 |
2011-08-31 |
CSL Behring AG |
Immunoglobulin preparation and storage system for an immunoglobulin preparation
|
|
DE102010011430A1
(de)
*
|
2010-03-15 |
2011-09-15 |
Kurt Koch |
Verfahren für den Bau des Nullenergiehauses in Schalenbauweise durch Ausschäumen aller Wände, Decken und Bedachung
|
|
CN102946875A
(zh)
|
2010-05-05 |
2013-02-27 |
贝林格尔.英格海姆国际有限公司 |
组合疗法
|
|
WO2011161161A1
(en)
|
2010-06-24 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Diabetes therapy
|
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
|
EP2649993B1
(en)
*
|
2010-12-09 |
2017-04-05 |
Maruishi Pharmaceutical Co., Ltd. |
Stabilizer of acetaminophen
|
|
EP2686002B1
(en)
|
2011-03-15 |
2018-01-24 |
Biogen Inc. |
Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
|
|
US8883800B2
(en)
|
2011-07-15 |
2014-11-11 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
|
WO2013159057A1
(en)
*
|
2012-04-19 |
2013-10-24 |
C. R. Bard, Inc. |
Infusates with enhanced ph stability under ethylene oxide sterilization
|
|
JP6218811B2
(ja)
|
2012-05-14 |
2017-10-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
|
|
JP6224084B2
(ja)
|
2012-05-14 |
2017-11-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
|
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
|
ITMI20120913A1
(it)
*
|
2012-05-28 |
2013-11-29 |
Nicoletta Maxia |
Uso della n-acetil-5-metossitriptamina o suoi analoghi per favorire il meccanismo di impianto dell' embrione, e relative composizioni e mezzi di coltura
|
|
CN103143000B
(zh)
*
|
2013-03-07 |
2014-11-05 |
安徽安科生物工程（集团）股份有限公司 |
一种重组人干扰素α2b制剂
|
|
EP3110449B1
(en)
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
|
JP2014208669A
(ja)
*
|
2014-06-17 |
2014-11-06 |
株式会社スリー・ディー・マトリックス |
タンパク質の凝集抑制剤
|
|
ES2988823T3
(es)
|
2014-12-03 |
2024-11-21 |
Csl Behring Ag |
Producto farmacéutico con mayor estabilidad que comprende inmunoglobulinas
|
|
CN109310697A
(zh)
|
2016-06-10 |
2019-02-05 |
勃林格殷格翰国际有限公司 |
利格列汀和二甲双胍的组合
|
|
KR101943160B1
(ko)
|
2016-10-06 |
2019-01-30 |
에이비온 주식회사 |
인터페론 베타 변이체의 안정화 제제
|
|
CN118370815A
(zh)
|
2017-08-22 |
2024-07-23 |
渤健马萨诸塞州股份有限公司 |
含有抗β淀粉样蛋白抗体的药物组合物
|
|
KR102731889B1
(ko)
*
|
2019-07-18 |
2024-11-19 |
에이비온 주식회사 |
2당화된 인터페론-베타 단백질의 정제 방법
|
|
CN110714051B
(zh)
*
|
2019-11-20 |
2023-04-07 |
迈克生物股份有限公司 |
蛋白c活性测定试剂盒
|
|
JP2023524248A
(ja)
*
|
2020-04-29 |
2023-06-09 |
アビオン インク． |
二重突然変異を有するヒトインターフェロン－ベータ変異体及びヒトインターフェロン－ベータ変異体の安全性を向上させる方法
|
|
WO2022207655A1
(en)
*
|
2021-03-30 |
2022-10-06 |
Schott Schweiz Ag |
System for low-temperature storage of a pharmaceutical composition, liquid composition, method and uses
|
|
CN114177273B
(zh)
*
|
2021-11-29 |
2024-05-28 |
苏州人本药业有限公司 |
一种含有神经毒素的液体制剂及其制备方法
|
|
WO2023129502A1
(en)
*
|
2021-12-27 |
2023-07-06 |
Enalare Therapeutics Inc. |
Respiratory stimulant parenteral formulations
|